This series of Business Stories is in collaboration with the Golden Bull award
Results vary, but many patients notice significant changes within 412 weeks
Initially, the research focused on treating diabetes and cardiovascular diseases (9,10,17,18)
Avoid fatty/greasy foods, sweets and alcohol
[6] [7] The SYNERGY-NASH phase 2 trial has investigated histological outcomes in patients with steatohepatitis and fibrosis, with preliminary data suggesting that a proportion of participants achieved resolution of hepatic steatosis, defined as liver fat content below 5%
Okojie, will work closely with you to develop a personalized plan that addresses any underlying hormonal imbalances or deficiencies that could be hindering your progress